Top Stories
Top Stories

UPDATE 1-Walgreens third-quarter profit beats estimates on higher pharmacy sales

sales@ (Adds third-quarter details, compares results with estimates)

June 27 (Reuters) - U.S. drugstore chain Walgreens Boots Alliance Inc's quarterly profit beat analysts' expectations on Thursday, as more people bought prescription drugs from its pharmacies.

Sales in its U.S. pharmacies rose 4.3% in the third quarter as it filed 290.7 million prescriptions.

The company maintained its full-year adjusted profit growth forecast. In April, Walgreens cut the forecast from a range of 7% to 12% to roughly flat.

"Following a difficult second quarter, we made progress in the third quarter against the strategic goals we set," Chief Executive Officer Stefano Pessina said in a statement.

In April, Walgreens said it would speed up cost cuts, which include shutting stores and consolidating warehouses, to stem some of the losses from the challenging market conditions. The company had estimated more than $1.5 billion in annual savings by 2022.

Net income attributable to Walgreens fell to $1.03 billion, or $1.13 per share, in the quarter ended May 31, from $1.34 billion, or $1.35 per share, a year earlier.

Excluding items, the company earned $1.47 per share, beating analysts' expectations of $1.43 per share, according to IBES data from Refinitiv.

Revenue rose nearly 1 percent to $34.59 billion. Analysts had expected revenue of $34.46 billion. (Reporting by Aakash Jagadeesh Babu and Manas Mishra in Bengaluru; Editing by Maju Samuel)